Literature DB >> 6622211

Improvement by super disintegrants of the properties of tablets containing lactose, prepared by wet granulation.

H V van Kamp, G K Bolhuis, C F Lerk.   

Abstract

The crushing strength, disintegration and dissolution properties of tablets, made by wet granulation with lactose as filter, gelatin as binder, potato starch as disintegrant and magnesium stearate as lubricant can be markedly improved when the potato starch (20%) is replaced by a much lower concentration (4%) of an insoluble super disintegrant, such as sodium starch glycolate (Primojel) or crospovidone (Polyplasdone XL). The incorporation of partially water soluble super disintegrants such as low-substituted sodium carboxymethylcellulose (Nymcel, ZSD 16), causing a viscous barrier in the tablets when containing water, is shown to be deleterious for both tablet disintegration and drug release. In contrast to potato starch, the position of the super disintegrants (intragranular, extragranular or equally distributed) had hardly any effect on the tablet properties. The improved properties of the tablets containing insoluble super disintegrants, when compared to tablets with potato starch, are the result of the use of a much lower concentration of disintegrant, but especially of the difference in effect of magnesium stearate on the disintegration capacity of the slightly swelling potato starch and the strongly swelling super disintegrants, respectively. The latter cause, even in the presence of the liquid penetration inhibiting hydrophobic magnesium stearate, a chain reaction of opening of the tablet, starting at the outside and resulting in a fast disintegration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6622211     DOI: 10.1007/bf01961475

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  8 in total

1.  Some aspects of the failure of sucrose tablets.

Authors:  H Groenwold; C F Lerk; R J Mulder
Journal:  J Pharm Pharmacol       Date:  1972-05       Impact factor: 3.765

2.  A new tablet disintegrating agent: cross-linked polyvinylpyrrolidone.

Authors:  S S Kornblum; S B Stoopak
Journal:  J Pharm Sci       Date:  1973-01       Impact factor: 3.534

3.  A comparative evaluation of some alginates as tablet disintegrants.

Authors:  K A Khan; C T Rhodes
Journal:  Pharm Acta Helv       Date:  1972-01

4.  [Effect of adjuvants on the speed of solubility in vitro of phenobarbital from different tablet formulae].

Authors:  F Jaminet; L Delattre; J P Delporte
Journal:  Pharm Acta Helv       Date:  1969-07

5.  [Effect of various disintegrating agents on the speed of dissolution of phenacetin tablets].

Authors:  C Boymond; D Gissinger; A Stamm
Journal:  Pharm Acta Helv       Date:  1982

6.  Interaction of tablet disintegrants and magnesium stearate during mixing I: Effect on tablet disintegration.

Authors:  G K Bolhuis; A J Smallenbroek; C F Lerk
Journal:  J Pharm Sci       Date:  1981-12       Impact factor: 3.534

7.  Interaction of tablet disintegrants and magnesium stearate during mixing. II. Effect on dissolution rate.

Authors:  C F Lerk; G K Bolhuis; A J Smallenbroek; K Zuurman
Journal:  Pharm Acta Helv       Date:  1982

8.  Effect of intragranular and extragranular disintegrating agents on particle size of disintegrated tablets.

Authors:  E Shotton; G S Leonard
Journal:  J Pharm Sci       Date:  1976-08       Impact factor: 3.534

  8 in total
  3 in total

1.  Effect of the mode of incorporation on the disintegrant properties of acid modified water and white yam starches.

Authors:  Oluwatoyin A Odeku; Babatunde L Akinwande
Journal:  Saudi Pharm J       Date:  2011-09-10       Impact factor: 4.330

Review 2.  A Review of Disintegration Mechanisms and Measurement Techniques.

Authors:  Daniel Markl; J Axel Zeitler
Journal:  Pharm Res       Date:  2017-03-01       Impact factor: 4.200

3.  Non-destructive Determination of Disintegration Time and Dissolution in Immediate Release Tablets by Terahertz Transmission Measurements.

Authors:  Daniel Markl; Johanna Sauerwein; Daniel J Goodwin; Sander van den Ban; J Axel Zeitler
Journal:  Pharm Res       Date:  2017-02-02       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.